Efficacy and safety of insulin glargine 300 U/mL in people with T2D in China: the INITIATION study

被引：0
|
作者：
Chen, L. [1 ,2 ]
Wan, H. [3 ]
Han, J. [4 ]
Yang, C. [5 ]
Shao, H. [6 ]
Li, J. [7 ]
Yan, W. [8 ]
Zhang, M. [9 ]
Li, M. [10 ]
Han, Y. [10 ]
Kang, L. [10 ]
机构：
[1] Chu Hsien I Mem Hosp, Tianjin Key Lab Metab Dis, NHC Key Lab Hormones & Dev, Tianjin, Peoples R China
[2] Tianjin Med Univ, Tianjin Inst Endocrinol, Dept Endocrinol, Tianjin, Peoples R China
[3] Panjin Cent Hosp, Dept Endocrinol, Panjin, Peoples R China
[4] Hebei PetroChina Cent Hosp, Dept Endocrinol, Langfang, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 6, Qingyuan Peoples Hosp, Dept Endocrinol, Qingyuan, Peoples R China
[6] Nankai Univ, Tianjin Ctr Hosp 4, Dept Endocrinol, Tianjin, Peoples R China
[7] Ningbo Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Ningbo, Peoples R China
[8] Huadu Dist Peoples Hosp Guangzhou, Dept Endocrinol, Guangzhou, Peoples R China
[9] Sanofi Investment Co Ltd, Med RWE, Shanghai, Peoples R China
[10] Sanofi Investment Co Ltd, Med Diabet, Shanghai, Peoples R China
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2024年 / 209卷
关键词：
D O I：
10.1016/j.diabres.2024.111432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF23-0184
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Device-Supported vs. Routine Titration of Insulin Glargine 300 U/mL (Gla-300) in T2DM: Efficacy and Safety
    Edelman, Steven
    Bain, Steve
    Hasslacher, Christoph
    Charpentier, Guillaume
    Vespasiani, Giacomo
    Flacke, Frank
    Goyeau, Harmonie
    Woloschak, Michael
    Davies, Melanie
    DIABETES, 2017, 66 : LB34 - LB34
  • [42] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
    Gagik R. Galstyan
    Amir Tirosh
    Hernando Vargas-Uricoechea
    Maria Aileen Mabunay
    Mathieu Coudert
    Mubarak Naqvi
    Valerie Pilorget
    Niaz Khan
    Diabetes Therapy, 2022, 13 : 1187 - 1202
  • [43] Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM Treated with Insulin Glargine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100)
    Bolli, Geremia
    Ritzel, Robert
    Yale, Jean-Francois
    Escalada, Javier
    Davies, Melanie
    Landgraf, Wolfgang
    Bertolini, Monica
    Hecquet, Carole
    Yki-Jarvinen, Hannele
    Rosenstock, Julio
    DIABETES, 2017, 66 : A258 - A258
  • [44] Real-World Health Outcomes of Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Glargine 100 U/mL (Gla-100) in Patients with Type 1 (T1D) and Type 2 Diabetes (T2D) in the Canadian LMC Diabetes Patient Registry-The REALITY Study
    Abitbol, Alexander
    Brown, Ruth E.
    Jiandani, Dishay
    Sauriol, Luc
    Aronson, Ronnie
    DIABETES, 2018, 67
  • [45] Clinical Outcome Assessment of the Effectiveness of Insulin Degludec (Degludec) in Real-life Medical Practice (CONFIRM)-A Comparative Effectiveness Study of Degludec and Insulin Glargine 300U/mL (Glargine U300) in Insulin-Naive Patients with Type 2 Diabetes (T2D)
    Tibaldi, Joseph
    Haldrup, Steffen
    Sandberg, Viktor
    Wolden, Michael L.
    Rodbard, Helena W.
    DIABETES, 2018, 67
  • [46] Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed-Ratio Combination in Elderly Patients with T2D
    Handelsman, Yehuda
    Chovanes, Christina
    Dex, Terry
    Giorgino, Francesco
    Skolnik, Neil
    Souhami, Elisabeth
    Stager, William
    Frias, Juan Pablo
    DIABETES, 2016, 65 : A246 - A246
  • [47] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND RENAL IMPAIRMENT: A SUBGROUP ANALYSIS OF ATOS STUDY
    Tirosh, A.
    Khan, N.
    Vargas-Uricoechea, H.
    Mabunay, M. A. N.
    Coudert, M.
    Pilorget, V.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A100 - A101
  • [48] Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) according to Baseline BMI
    Kis, Janos T.
    Seufert, Jochen
    Haluzik, Martin
    Vera, Carine
    Tournay, Mathilde
    Bonnemaire, Mireille
    Freemantle, Nick
    Guja, Cristian
    DIABETES, 2024, 73
  • [49] Efficacy and Safety of Insulin Degludec (IDeg) vs. Insulin Glargine U100 (IGlar) in Hispanic Patients with Type 2 Diabetes (T2D)
    Chaykin, Louis B.
    Bhargava, Anuj
    Wysham, Carol H.
    Abrahamsen, Trine
    Van Leeuwen, Michiel
    De la Rosa, Raymond
    DIABETES, 2017, 66 : A617 - A617
  • [50] New Insulin Glargine 300 U/ml: Glycemic Control and Hypoglycemia in Insulin Naive People with T2DM (EDITION 3)
    Bolli, Geremia B.
    Riddle, Matthew C.
    Bergenstal, Richard M.
    Ziemen, Monika
    Sestakauskas, Kastytis
    Goyeau, Harmonie
    Home, Phillip D.
    DIABETES, 2014, 63 : A19 - A19
12345